v3.25.1
Revenue (Tables)
3 Months Ended
Mar. 30, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table summarizes Total revenues by business unit:
Three Months Ended
(In millions)March 30, 2025March 31, 2024
Labs$373.1 $356.9 
Immunohematology (1)
128.5 127.0 
Donor Screening (1)
12.8 33.3 
Point of Care170.8 186.6 
Molecular Diagnostics7.6 7.2 
Total revenues$692.8 $711.0 
(1) For presentation purposes, as a result of the wind-down of the U.S. donor screening portfolio, the previously reported Transfusion Medicine business unit is shown in its two product categories: Immunohematology and Donor Screening. Prior periods have been revised to align with the current period presentation.